A tumor immune barrier (TIB) formed by crosstalk between SPP1 macrophages and CAFs created an immunosuppressive microenvironment that hindered peripheral tumor infiltration of immune cells such as CD8+ T cells, thereby suppressing immunotherapy efficacy in hepatocellular carcinoma (HCC). Here, CD8A is linked to hepatocellular carcinoma.